Quinz‘s practice stands out for its strong transactional and regulatory capabilities, often advising on transparency regulations, healthcare compliance matters, and competition issues. Olivier Van Obberghen has a solid track record in handling pharma compliance work and supply chain projects; he co-heads the practice with Pieter Wyckmans, who is well versed in advising on market access issues and pricing and reimbursement work. International research collaboration matters form a key pillar of Michiel D’herde's practice, and Marion Lapage fields expertise in R&D outsourcing projects and distribution issues. Amber Cockx often advises on digital health matters, and Pauline Meskens focuses on market access and parallel imports issues.
Legal 500 redaktioneller Kommentar
Auszeichnungen
Mandantenzufriedenheit
Referenzen
Unabhängig vom Legal 500-Forschungsteam zusammengestellt.
‘We work with Dries Vanpaemel and Amber Cockx. Dries is very experienced in contract law and covers a broad range of contracting capabilities (including supply/distribution). Amber provides great legal support on regulatory/compliance related matters. Both are well positioned to transfer legal requirements into practical solutions.’
‘Great team with great expertise and practical experience.’
‘What sets them apart is their unwavering dedication and sense of purpose. Their commitment to delivering excellence is evident in every engagement.’
‘Quinz’s support has always been flawless, straight to the point and perfectly tailored to my needs. Quinz is impressive in terms of its experience and expertise, as well as regarding its dedication for the life sciences sector that each individual team member clearly shows. Furthermore, they follow a holistic approach and clients highly profit from their multidisciplinary perspective on each project.’
‘Olivier Van Obberghen and Pieter Wyckmans are truly passionate about life sciences and are extremely reliable, experienced and knowledgeable. Pieter has an unequalled knowledge of the Belgian pricing and reimbursement landscape and is a brilliant and creative negotiator. Olivier is definitely the go-to person for healthcare compliance in Belgium and is a gifted and inspirational speaker on this subject. Furthermore, the whole team is super pleasant to work with.’
‘We work with Olivier Van Obberghen and Pieter Wyckmans, both of them are excellent and fantastic legal support in Belgium.’
‘Pieter Wyckmans and Olivier Van Obberghen are humble, but have deep experience, pushing back when needed, but looking for solutions where possible.'
Kernmandanten
- Johnson & Johnson
- UCB Pharma
- Takeda
- Galapagos
- Telix Pharmaceuticals
- Vertex
- Bayer
- ExeVir
- Abscint
- Priothera
Highlight-Mandate
- Represented Recordati in a dispute against parallel importer PI Pharma, involving the issue of parallel importers trading generic medicines under the brand name of an originator medicine.
- Advised the Belgian governmental institution KCE on developing a roadmap for academic institutions and hospitals to manufacture and commercially launch advanced therapies under their own proprietary IP and marketing authorisation.
- Assisted Vifor with a challenge to a disproportional price decrease of Vifor’s Injectafer® product.
Anwält*innen
Führende Partner*innen
Die stärksten Partner*innen ihres Praxisbereichs, die eine führende Rolle in signifikanten Mandaten einnehmen und weitreichende Anerkennung unter Wettbewerbern und Mandanten genießen.
Führende Associates
Führende Associates sind regelmäßig an zentralen Mandaten des Teams beteiligt und erhalten positives Feedback von Wettbewerbern oder Mandanten.
Praxisleitung
Olivier Van Obberghen; Pieter Wyckmans
Weitere Kernanwält*innen
Michiel D’herde; Marion Lapage; Amber Cockx; Pauline Meskens; Dries Vanpaemel